Lv1
30 积分 2025-12-29 加入
A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism
28天前
已完结
Efficacy of cinacalcet with low-dose vitamin D in incident haemodialysis subjects with secondary hyperparathyroidism
28天前
已完结
Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results
1个月前
已完结
242: A Randomized Controlled Trial to Evaluate the Effects of Cinacalcet Plus Low-Dose Vitamin D on Vascular Calcification in Hemodialysis Patients
1个月前
已完结
A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism
1个月前
已完结
Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol
1个月前
已完结
AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patients
1个月前
已完结
MP368A NOVEL INTRAVENOUS CALCIMIMETIC, ONO-5163 (ETELCALCETIDE): A MULTICENTER, SINGLE AND MULTIPLE DOSE STUDY IN JAPANESE HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
1个月前
已完结
A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients
1个月前
已完结
皖公网安备34019202002308
